Drug
encorafenib
Marketed as BRAFTOVI.
Generic name
encorafenib
Brand names
BRAFTOVI
First FDA approval
2018-06-27
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA210496 | BRAFTOVI | 2018-06-27 | ARRAY BIOPHARMA INC |
Manufacturers
ARRAY BIOPHARMA INC
Frequently asked questions
When was encorafenib FDA approved?
Earliest FDA approval on record: 2018-06-27.
What brand names are sold as encorafenib?
BRAFTOVI.
Sources
Appeal a encorafenib denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com